GLIOBLASTOMA MULTIFORME
Clinical trials for GLIOBLASTOMA MULTIFORME explained in plain language.
Never miss a new study
Get alerted when new GLIOBLASTOMA MULTIFORME trials appear
Sign up with your email to follow new studies for GLIOBLASTOMA MULTIFORME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill joins fight against deadly brain cancer
Disease control Not yet recruitingThis trial is testing if adding a new oral medication called NG101m to the standard treatment helps people with newly diagnosed glioblastoma live longer. About 52 adults will take NG101m capsules along with their usual chemotherapy and radiation. The main goal is to see if this c…
Matched conditions: GLIOBLASTOMA MULTIFORME
Phase: PHASE1, PHASE2 • Sponsor: NeuGATE Theranostics • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New hope for deadly brain cancer: experimental drug enters human trials
Disease control Not yet recruitingThis early-stage trial is testing a new drug called LMP744 in adults whose aggressive brain cancer (glioblastoma) has returned after standard treatment. The main goal is to see if the drug can shrink tumors and slow the cancer's progression. Participants will receive the drug thr…
Matched conditions: GLIOBLASTOMA MULTIFORME
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Disease control
Last updated Mar 16, 2026 15:23 UTC